利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

11 条记录 (耗时 0.032 秒)

    Fused heterocyclic compounds
    1.
    发明授权
    Fused heterocyclic compounds 失效
    稠合杂环化合物

    公开(公告)号：US06809104B2

    公开(公告)日：2004-10-26

    申请号：US10289933

    申请日：2002-11-06

    申请人： Xiaoqi Chen ,  Pingchen Fan ,  Juan Jaen ,  Leping Li ,  Mike Lizarzaburu ,  Jeffrey Thomas Mihalic ,  Stephen Joseph Shuttleworth

    发明人： Xiaoqi Chen ,  Pingchen Fan ,  Juan Jaen ,  Leping Li ,  Mike Lizarzaburu ,  Jeffrey Thomas Mihalic ,  Stephen Joseph Shuttleworth

    IPC分类号： C07D47104

    CPC分类号： C07D471/04

    摘要： Compounds having the formula: wherein L is a bond or (C1-C4)alkylene, R″ is hydrogen or (C1-C8)alkyl, and R1, R2, R4, R, R′, and the subscript n are as described herein, are provided, which are useful in the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor. Pharmaceutical compositions and methods of using these compounds for the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor, such as eating disorders, obesity, anxiety disorders and mood disorders, are also provided.

    摘要翻译： 具有下式的化合物：其中L是一个键或（C 1 -C 4）亚烷基，R“是氢或（C 1 -C 8）烷基，R 1，R 2，R 4，R，R '和下标n如本文所述，其可用于治疗和/或预防由G蛋白偶联受体介导的病症或病症。 还提供了使用这些化合物治疗和/或预防由G蛋白偶联受体介导的病症或病症的药物组合物和方法，例如进食障碍，肥胖症，焦虑障碍和情绪障碍。

    Combination therapeutic compositions and methods of use
    10.
    发明申请
    Combination therapeutic compositions and methods of use 失效
    组合治疗组合物和使用方法

    公开(公告)号：US20060035928A1

    公开(公告)日：2006-02-16

    申请号：US11258817

    申请日：2005-10-26

    申请人： Juan Jaen ,  Jin-Long Chen

    发明人： Juan Jaen ,  Jin-Long Chen

    IPC分类号： A61K31/47 ,  A61K31/165

    CPC分类号： A61K45/06 ,  A61K31/00 ,  A61K31/165 ,  A61K31/47 ,  Y10S514/866 ,  A61K2300/00

    摘要： The present invention provides pharmaceutical compositions and methods for the treatment of diabetes mellitus using combination therapy. The compositions relate to a compound of Formula I and an antidiabetic agent such as sulfonylureas, biguanides, glitazones, α-glucosidase inhibitors, potassium channel antagonists, aldose reductase inhibitors, glucagon antagonists, activators of RXR, insulin therapy or other anti-obesity agent. The methods include the administration of the combination of compound of Formula I with antidiabetic agent where the two components are delivered in a simultaneous manner, where the compound of Formula I is administered first, followed by the antidiabetic agent, as well as wherein the antidiabetic agent is delivered first followed by the compound of Formula I.

    摘要翻译： 本发明提供了使用组合疗法治疗糖尿病的药物组合物和方法。 组合物涉及式I化合物和抗糖尿病药如磺酰脲类，双胍类，格列酮，α-葡糖苷酶抑制剂，钾通道拮抗剂，醛糖还原酶抑制剂，胰高血糖素拮抗剂，RXR的激活剂，胰岛素治疗或其它抗肥胖剂。 所述方法包括施用式I化合物与抗糖尿病药物的组合，其中两种成分以同时方式递送，其中首先给予式I化合物，然后是抗糖尿病药，以及其中抗糖尿病药 首先交付，然后是式I的化合物。